Article Details

Oxford/AstraZeneca vaccine: rare blood clot syndrome has high mortality rate

Retrieved on: 2021-08-11 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

Oxford/AstraZeneca vaccine: rare blood clot syndrome has high mortality rate. View article details on hiswai:

Excerpt

“It's important to stress that this kind of reaction to the Oxford/AstraZeneca vaccine is very rare,” said Dr Sue Pavord, consultant haematologist at Oxford ...

Article found on: www.theguardian.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up